X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/03/25/2851602/0/en/ZyVersa-Therapeutics-Reports-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2024/03/18/2847718/0/en/ZyVersa-Therapeutics-Announces-IRB-Approval-of-Phase-2a-Clinical-Trial-Protocol-to-Evaluate-Cholesterol-Efflux-Mediator-VAR-200-in-Patients-with-Diabetic-Kidney-Disease.html
https://www.globenewswire.com//news-release/2024/01/24/2815197/0/en/ZyVersa-Therapeutics-Announces-Peer-Reviewed-Article-Supporting-the-Therapeutic-Potential-of-Targeting-ASC-Specks-During-Progression-of-Alzheimer-s-Disease.html
https://www.fiercebiotech.com/cro/zyversa-taps-george-clinical-run-kidney-disease-trial
https://www.globenewswire.com//news-release/2023/12/07/2792616/0/en/Biomea-Fusion-to-Present-Long-Term-Follow-Up-Data-from-Ongoing-Phase-II-Study-COVALENT-111-of-BMF-219-in-Adults-with-Type-2-Diabetes-and-Results-from-Ex-Vivo-Human-Islet-Experiment.html
https://www.globenewswire.com//news-release/2023/11/01/2771146/0/en/ZyVersa-Therapeutics-Announces-Publication-in-Molecular-Neurobiology-Reinforcing-Data-Demonstrating-That-Inflammasome-ASC-Inhibitor-IC-100-Attenuates-the-Inflammatory-Response-Caus.html
https://www.globenewswire.com//news-release/2023/10/11/2758219/0/en/ZyVersa-Therapeutics-Announces-Peer-Reviewed-Publication-in-Nature-Reviews-Nephrology-Substantiating-VAR-200-s-Rationale-for-Mediating-Transport-of-Cholesterol-and-Lipids-Out-of-Ki.html
https://www.globenewswire.com//news-release/2023/09/12/2741445/0/en/ZyVersa-Therapeutics-Announces-Research-Published-in-Frontiers-in-Immunology-Reinforcing-IC-100-s-Rationale-for-Inhibiting-Multiple-Inflammasomes-to-Control-Inflammation-in-Various.html
https://www.globenewswire.com/news-release/2023/07/24/2709461/0/en/ZyVersa-Therapeutics-Inc-Announces-Pricing-of-2-1-Million-Public-Offering.html
https://www.globenewswire.com/news-release/2023/07/17/2705227/0/en/ZyVersa-Therapeutics-Announces-Publication-in-the-Journal-Hepatology-Highlighting-the-Role-of-NLRP3-Inflammasome-Mediated-IL-18-in-Development-of-Liver-Fibrosis.html
Market Place
Share 
